Literature DB >> 8100199

Prognostic factors of early fatal outcome and long-term survival in patients with Pneumocystis carinii pneumonia and acquired immunodeficiency syndrome.

A Antinori1, G Maiuro, F Pallavicini, F Valente, G Ventura, G Marasca, R Murri, E Pizzigallo, G Camilli, E Tamburrini.   

Abstract

Fifty-five episodes of Pneumocystis carinii pneumonia (PCP) in AIDS patients were evaluated to assess clinical and laboratory risk factors predicting the probability of surviving the acute episode of PCP and the long-term survival after PCP. Age > 45 yrs, PaO2 < 50 mmHg, AaPO2 > 50 mmHg, and LDH > 800 IU/L correlated strongly with early mortality; patients who needed mechanical ventilation had a significantly lower PaO2 and serum albumin, and higher AaPO2 and LDH compared to the patients who did not. Neither age nor PaO2, AaPO2, LDH, albumin, days from onset, time for recovery, CD4+ cell count correlated with long-term survival of AIDS patients with PCP. Informations obtained at initial presentation of PCP may predict early outcome and influence therapeutic approach, improving chances for survival.

Entities:  

Mesh:

Year:  1993        PMID: 8100199     DOI: 10.1007/bf00158789

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  28 in total

1.  Prognostic score for Pneumocystis carinii pneumonia.

Authors:  R Speich; R Weber; C M Kronauer; M Opravil; R Lüthy; E W Russi
Journal:  Respiration       Date:  1990       Impact factor: 3.580

2.  Survival and prognostic factors in severe Pneumocystis carinii pneumonia requiring mechanical ventilation.

Authors:  W el-Sadr; M S Simberkoff
Journal:  Am Rev Respir Dis       Date:  1988-06

3.  Confidence intervals for reporting results of clinical trials.

Authors:  R Simon
Journal:  Ann Intern Med       Date:  1986-09       Impact factor: 25.391

4.  Improved survival in patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure.

Authors:  Y Friedman; C Franklin; E C Rackow; M H Weil
Journal:  Chest       Date:  1989-10       Impact factor: 9.410

5.  The diagnosis of Pneumocystis carinii pneumonia in patients with the acquired immunodeficiency syndrome using subsegmental bronchoalveolar lavage.

Authors:  F P Ognibene; J Shelhamer; V Gill; A M Macher; D Loew; M M Parker; E Gelmann; A S Fauci; J E Parrillo; H Masur
Journal:  Am Rev Respir Dis       Date:  1984-06

6.  Pneumocystis carinii pneumonia: a comparison between patients with the acquired immunodeficiency syndrome and patients with other immunodeficiencies.

Authors:  J A Kovacs; J W Hiemenz; A M Macher; D Stover; H W Murray; J Shelhamer; H C Lane; C Urmacher; C Honig; D L Longo
Journal:  Ann Intern Med       Date:  1984-05       Impact factor: 25.391

7.  Risk stratification of ambulatory patients suspected of Pneumocystis pneumonia.

Authors:  M H Katz; R B Baron; D Grady
Journal:  Arch Intern Med       Date:  1991-01

8.  Opportunistic diseases reported in AIDS patients: frequencies, associations, and trends.

Authors:  R M Selik; E T Starcher; J W Curran
Journal:  AIDS       Date:  1987-09       Impact factor: 4.177

9.  Correlation of bronchoalveolar lavage cell populations with clinical severity of Pneumocystis carinii pneumonia.

Authors:  R L Smith; W M el-Sadr; M L Lewis
Journal:  Chest       Date:  1988-01       Impact factor: 9.410

10.  Aerosolized pentamidine for prophylaxis against Pneumocystis carinii pneumonia. The San Francisco community prophylaxis trial.

Authors:  G S Leoung; D W Feigal; A B Montgomery; K Corkery; L Wardlaw; M Adams; D Busch; S Gordon; M A Jacobson; P A Volberding
Journal:  N Engl J Med       Date:  1990-09-20       Impact factor: 91.245

View more
  3 in total

1.  Hematological and biochemical factors predicting SARS fatality in Taiwan.

Authors:  Hsiao-Ling Chang; Kow-Tong Chen; Shu-Kuan Lai; Hung-Wei Kuo; Ih-Jen Su; Ruey S Lin; Fung-Chang Sung
Journal:  J Formos Med Assoc       Date:  2006-06       Impact factor: 3.282

2.  Risk factors of in-hospital mortality in patients with pneumocystis pneumonia diagnosed by metagenomics next-generation sequencing.

Authors:  Jun-Na Hou; Heng-Dao Liu; Qiu-Yue Tan; Feng-An Cao; Shi-Lei Wang; Meng-Ying Yao; Yang-Chao Zhao
Journal:  Front Cell Infect Microbiol       Date:  2022-09-26       Impact factor: 6.073

3.  Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years.

Authors:  Julius J Schmidt; Catherina Lueck; Stefan Ziesing; Matthias Stoll; Hermann Haller; Jens Gottlieb; Matthias Eder; Tobias Welte; Marius M Hoeper; André Scherag; Sascha David
Journal:  Crit Care       Date:  2018-11-19       Impact factor: 9.097

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.